HCA vs. GILD, BMY, ZTS, GSK, MCK, CI, BDX, BSX, REGN, and VRTX
Should you be buying HCA Healthcare stock or one of its competitors? The main competitors of HCA Healthcare include Gilead Sciences (GILD), Bristol-Myers Squibb (BMY), Zoetis (ZTS), GSK (GSK), McKesson (MCK), The Cigna Group (CI), Becton, Dickinson and Company (BDX), Boston Scientific (BSX), Regeneron Pharmaceuticals (REGN), and Vertex Pharmaceuticals (VRTX). These companies are all part of the "medical" sector.
Gilead Sciences (NASDAQ:GILD) and HCA Healthcare (NYSE:HCA) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, community ranking, institutional ownership and dividends.
Gilead Sciences has a beta of 0.22, suggesting that its stock price is 78% less volatile than the S&P 500. Comparatively, HCA Healthcare has a beta of 1.66, suggesting that its stock price is 66% more volatile than the S&P 500.
Gilead Sciences received 1251 more outperform votes than HCA Healthcare when rated by MarketBeat users. Likewise, 77.37% of users gave Gilead Sciences an outperform vote while only 77.33% of users gave HCA Healthcare an outperform vote.
Gilead Sciences pays an annual dividend of $3.08 per share and has a dividend yield of 4.5%. HCA Healthcare pays an annual dividend of $2.64 per share and has a dividend yield of 0.8%. Gilead Sciences pays out 855.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. HCA Healthcare pays out 13.2% of its earnings in the form of a dividend. Gilead Sciences has raised its dividend for 9 consecutive years and HCA Healthcare has raised its dividend for 5 consecutive years. Gilead Sciences is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Gilead Sciences has higher earnings, but lower revenue than HCA Healthcare. HCA Healthcare is trading at a lower price-to-earnings ratio than Gilead Sciences, indicating that it is currently the more affordable of the two stocks.
83.7% of Gilead Sciences shares are owned by institutional investors. Comparatively, 62.7% of HCA Healthcare shares are owned by institutional investors. 0.2% of Gilead Sciences shares are owned by insiders. Comparatively, 1.6% of HCA Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
HCA Healthcare has a net margin of 8.20% compared to HCA Healthcare's net margin of 1.76%. Gilead Sciences' return on equity of 674.49% beat HCA Healthcare's return on equity.
Gilead Sciences currently has a consensus price target of $83.69, indicating a potential upside of 23.58%. HCA Healthcare has a consensus price target of $317.00, indicating a potential downside of 1.82%. Given HCA Healthcare's higher possible upside, equities research analysts clearly believe Gilead Sciences is more favorable than HCA Healthcare.
In the previous week, HCA Healthcare had 8 more articles in the media than Gilead Sciences. MarketBeat recorded 25 mentions for HCA Healthcare and 17 mentions for Gilead Sciences. HCA Healthcare's average media sentiment score of 0.45 beat Gilead Sciences' score of 0.28 indicating that Gilead Sciences is being referred to more favorably in the media.
Summary
HCA Healthcare beats Gilead Sciences on 11 of the 21 factors compared between the two stocks.
Get HCA Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for HCA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HCA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
HCA Healthcare Competitors List
Related Companies and Tools
